Cryo-Cell International (CCEL) closed at $4.96 on October 27, 2026, down 1.0% from the previous close, on volume of 3,271 shares (30-day average 12,340).
Data as of October 27, 2026.
CCEL rallies after fiscal Q3 net income rises to $1.27M on flat revenue
Market Chameleon (Mon, 12-Oct 7:28 AM ET)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results
Business Wire (Fri, 9-Oct 4:30 PM ET)
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Cryo-Cell International trades on the AMEX stock market under the symbol CCEL.
As of October 27, 2026, CCEL stock price declined to $4.96 with 3,271 million shares trading.
CCEL has a beta of 0.90, meaning it tends to be less sensitive to market movements. CCEL has a correlation of 0.04 to the broad based SPY ETF.
CCEL has a market cap of $39.96 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, CCEL traded as high as $9.50 and as low as $2.72.
The top ETF exchange traded funds that CCEL belongs to (by Net Assets): VTI, VXF.
CCEL has underperformed the market in the last year with a return of +8.5%, while SPY returned +13.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CCEL shares. However, CCEL has outperformed the market in the last 3 month and 2 week periods, returning +50.3% and +15.3%, while SPY returned +4.4% and -1.1%, respectively. This indicates CCEL has been having a stronger performance recently.
CCEL support price is $4.61 and resistance is $5.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CCEL shares will trade within this expected range on the day.
